Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance

PARIS, FRANCE, 22 October 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the year to date and the third quarter of 2025.